Literature DB >> 20223885

Brain MR imaging and 1H-MR spectroscopy changes in patients with extrahepatic portal vein obstruction from early childhood to adulthood.

S K Yadav1, S Saksena, Anshu Srivastava, Arti Srivastava, V A Saraswat, M A Thomas, R K S Rathore, Rakesh K Gupta.   

Abstract

BACKGROUND AND
PURPOSE: MR imaging and (1)H-MR spectroscopy changes are well reported in cirrhotic patients, whereas they are inadequately reported in EHPVO. The aim of this study was to investigate age-related changes in brain MR imaging and metabolite profile in EHPVO with and without MHE and to explore any correlation of imaging and (1)H-MR spectroscopy parameters with blood ammonia.
MATERIALS AND METHODS: Sixty-three patients with EHPVO (children, 7-12 years [n = 22], adolescents, 13-18 years [n = 15] and adults, 19-41 years [n = 26]) and 47 healthy age/sex-matched volunteers were studied. Neuropsychological tests, MR imaging, (1)H-MR spectroscopy, and blood ammonia estimation were performed in all subjects.
RESULTS: Of 63 EHPVO patients, 25 (40%) who had MHE showed significantly increased MD, Glx, and blood ammonia in all 3 age groups; however, myo-inositol was significantly lower only in adults when compared with controls. MD positively correlated with blood ammonia and Glx in all age groups. Brain choline levels were normal in all patients with different age groups.
CONCLUSIONS: Increases in brain MD, Glx, and blood ammonia were associated with MHE in all age groups. Normal brain choline in EHPVO signifies healthy liver and may serve as a diagnostic marker for its differentiation from cirrhosis-induced encephalopathy. Significant decrease of myo-inositol in adults is probably due to cellular osmoregulation secondary to long-standing hyperammonemia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223885      PMCID: PMC7965449          DOI: 10.3174/ajnr.A2045

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  27 in total

1.  Comparison of gradient encoding schemes for diffusion-tensor MRI.

Authors:  K M Hasan; D L Parker; A L Alexander
Journal:  J Magn Reson Imaging       Date:  2001-05       Impact factor: 4.813

2.  Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy.

Authors:  R Kreis; N Farrow; B D Ross
Journal:  Lancet       Date:  1990-09-08       Impact factor: 79.321

Review 3.  The application of magnetic resonance spectroscopy to the study of hepatic encephalopathy.

Authors:  J P Seery; S D Taylor-Robinson
Journal:  J Hepatol       Date:  1996-12       Impact factor: 25.083

4.  Factors associated with poor health-related quality of life of patients with cirrhosis.

Authors:  G Marchesini; G Bianchi; P Amodio; F Salerno; M Merli; C Panella; C Loguercio; G Apolone; M Niero; R Abbiati
Journal:  Gastroenterology       Date:  2001-01       Impact factor: 22.682

Review 5.  Quality of life in cirrhotics with minimal hepatic encephalopathy.

Authors:  H Schomerus; W Hamster
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

6.  Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema.

Authors:  J Cordoba; J Gottstein; A T Blei
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

7.  Minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.

Authors:  Praveen Sharma; Barjesh C Sharma; Vinod Puri; Shiv K Sarin
Journal:  Am J Gastroenterol       Date:  2008-05-28       Impact factor: 10.864

8.  Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts.

Authors:  María Ortiz; Juan Córdoba; Juli Alonso; Alex Rovira; Sergi Quiroga; Carlos Jacas; Rafael Esteban; Jaume Guardia
Journal:  J Hepatol       Date:  2004-03       Impact factor: 25.083

9.  Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.

Authors:  Beatriz Mínguez; Juan Carlos García-Pagán; Jaume Bosch; Juan Turnes; Juli Alonso; Alex Rovira; Juan Córdoba
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

10.  In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.

Authors:  Ashish Verma; Vivek Anand Saraswat; Y Radha Krishna; Kavindra Nath; M Albert Thomas; Rakesh Kumar Gupta
Journal:  Liver Int       Date:  2008-02-08       Impact factor: 5.828

View more
  5 in total

Review 1.  Multimodality MR imaging findings of low-grade brain edema in hepatic encephalopathy.

Authors:  L J Zhang; J Zhong; G M Lu
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-01       Impact factor: 3.825

2.  Minimal hepatic encephalopathy in children with liver cirrhosis: diffusion-weighted MR imaging and proton MR spectroscopy of the brain.

Authors:  Ahmed Abdel Khalek Abdel Razek; Ahmed Abdalla; Amany Ezzat; Ahmed Megahed; Tarek Barakat
Journal:  Neuroradiology       Date:  2014-07-25       Impact factor: 2.804

3.  Neurodevelopmental Outcome of Young Children with Biliary Atresia and Native Liver: Results from the ChiLDReN Study.

Authors:  Vicky L Ng; Lisa G Sorensen; Estella M Alonso; Emily M Fredericks; Wen Ye; Jeff Moore; Saul J Karpen; Benjamin L Shneider; Jean P Molleston; Jorge A Bezerra; Karen F Murray; Kathleen M Loomes; Philip Rosenthal; Robert H Squires; Kasper Wang; Ronen Arnon; Kathleen B Schwarz; Yumirle P Turmelle; Barbara H Haber; Averell H Sherker; John C Magee; Ronald J Sokol
Journal:  J Pediatr       Date:  2018-03-05       Impact factor: 4.406

4.  Insular cortex metabolite changes in obstructive sleep apnea.

Authors:  Santosh K Yadav; Rajesh Kumar; Paul M Macey; Mary A Woo; Frisca L Yan-Go; Ronald M Harper
Journal:  Sleep       Date:  2014-05-01       Impact factor: 5.849

5.  Brain Microstructural Correlates of Cognitive Dysfunction in Clinically and Biochemically Normal Hepatitis C Virus Infection.

Authors:  Ajay Kumar; Amar Deep; Rakesh K Gupta; Virendra Atam; Samir Mohindra
Journal:  J Clin Exp Hepatol       Date:  2017-04-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.